The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Intersection of ATMPs and New Technologies | Advanced Therapy Medicinal Products (ATMPs), are medicines for human use that are based on genes, tissues, or cells. ATMPs offer novel ways to treat a variety of diseases, and in some instances can be curative. As ATMPs move out of the clinic and become commercialized, manufacturers face traditional challenges of scale-up, transfer and the application of new technologies. This session will explore this intersection. You will hear from experts in the field who will provide valuable technical insight and case studies to the participants.
Session Leader(s):
Mr. Michael
G. Higgins,
Sr. Director External Engagement and Supplier Quality,
Moderna Therapeutics